WT1 and cancer: To comprehensively evaluate our predictions, we used several benchmark gene sets (see the Methods), including EWSR1-WT1 fusion-related genes, DSRCT-related genes, and cancer pathway genes as well as a set of genes whose promoter regions were found to be peak binding sites of WT1 by ChIP-Seq38.